Efficacy and Safety of DWJ1248 With Remdesivir in Severe COVID-19 Patients
Clinical trial NCT04713176 · TERMINATED
Trial details
- NCT number
- NCT04713176
- Sponsor
- Daewoong Pharmaceutical Co. LTD.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-02
- Primary completion
- 2022-05-02
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.